Ocular Therapeutix, Inc. (OCUL)

9.49 +0.54 (+5.97%) USD  |  NASDAQ  |  Feb 25, 16:00
9.54 +0.05 (+0.53%) After-Hours: 19:21
More

Ocular Therapeutix Other Operating Expenses (Quarterly)

Other Operating Expenses (Quarterly) Chart

View Other Operating Expenses (Quarterly) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Operating Expenses (Quarterly) Range, Past 5 Years

View Other Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Operating Expenses (Quarterly) Benchmarks

View Other Operating Expenses (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. --
Boston Scientific Corp. Upgrade
Alnylam Pharmaceuticals, Inc. --
EyePoint Plc --
Vertex Pharmaceuticals, Inc. --